Laurent Crenier

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Medicine, Endocrinology, Immunology +17

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 313 citations · Full text

Medicine, Endocrinology, Immunology +14

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

Annieke C.G. van Baar, F. Holleman, Laurent Crenier et al. · Gut · 2019 · 196 citations · Full text

Medicine, Endocrinology, Surgery +13

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Sara Charleer, Chantal Mathieu, Frank Nobels et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 189 citations · Full text

Medicine, Clinical Pharmacy, Internal Medicine +17